Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO5285119 comparative bioavailability crossover study in healthy volunteers
NL-OMON44542Active, not recruiting
- Sponsor
- Roche
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of balovaptan in Autism Spectrum Disorder (ASD) (4 arms), sponsored by Roche. Started Aug 2017; status: active, not recruiting.
02
Drugs
balovaptan
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NL-OMON44542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44542.